Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints. by Brueggemann, A, Doern, G

Resistance among Streptococcus pneumoniae: Patterns, mechanisms, interpreting the breakpoints by Brueggemann, A, Doern, G

Resistance among Streptococcus pneumoniae: Patterns, mechanisms, interpreting the breakpoints by Brueggemann, A, Doern, G

Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae. by Doern, G, Brueggemann, A, Pierce, G

Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae. by Brueggemann, A, Pfaller, M, Doern, G

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. by Diekema, D, Brueggemann, A, Doern, G

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella... by Brueggemann, A, Kugler, K, Doern, G

In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. by Doern, G, Pierce, G, Brueggemann, A

Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Mic... by Doern, G, Brueggemann, A, Pfaller, M, Jones, R

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. by Doern, G, Brueggemann, A, Huynh, H, Wingert, E

Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. by Murphy, T, Sethi, S, Klingman, K, Brueggemann, A, Doern, G

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surve... by Doern, G, Brueggemann, A, Holley, H, Rauch, A

Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. by Doern, G, Ferraro, M, Brueggemann, A, Ruoff, K

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 199... by Shortridge, V, Doern, G, Brueggemann, A, Beyer, J, Flamm, R

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from... by Doern, G, Pfaller, M, Erwin, M, Brueggemann, A, Jones, R

Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia. by Dickson, E, Heard, S, Tarara, T, Weers, J, Brueggemann, A, Doern, G

In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. by Brueggemann, A, Doern, G, Huynh, H, Wingert, E, Rhomberg, P

Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicil... by Doern, G, Brueggemann, A, Pierce, G, Holley, H, Rauch, A

Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia. by Dickson, E, Heard, S, Chu, B, Fraire, A, Brueggemann, A, Doern, G

Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national survei... by Doern, G, Brueggemann, A, Pierce, G, Hogan, T, Holley, H, Rauch, A